Showing results (1-10 of 1,122) with videos related to
Sort By:
Pageof 113
The Journal of Antimicrobial Chemotherapy|October 5, 2007
Evaluation of the chromogenic Cica-beta-Test for detecting extended-spectrum, AmpC and metallo-beta-lactamasesD M Livermore, M Warner, S MushtaqClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producersD M Livermore, R Hope, S Mushtaq, et al.International Journal of Antimicrobial Agents|September 24, 2004
Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolidA P Johnson, S Mushtaq, M Warner, et al.The Journal of Antimicrobial Chemotherapy|May 19, 2010
Activity of chequerboard combinations of ceftaroline and NXL104 versus beta-lactamase-producing EnterobacteriaceaeS Mushtaq, M Warner, G Williams, et al.The Journal of Antimicrobial Chemotherapy|October 9, 2010
Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UKR Hope, S Mushtaq, D James, et al.The Journal of Antimicrobial Chemotherapy|November 16, 2005
Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclinesR Hope, M Warner, S Mushtaq, et al.The Journal of Hospital Infection|July 12, 2003
Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agentsA P Johnson, C Henwood, S Mushtaq, et al.The Journal of Antimicrobial Chemotherapy|November 17, 2010
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolatesD M Livermore, S Mushtaq, M Warner, et al.The Journal of Antimicrobial Chemotherapy|June 23, 2016
New insights into the regulatory pathways associated with the activation of the stringent response in bacterial resistance to the PBP2-targeted antibiotics, mecillinam and OP0595/RG6080M Doumith, S Mushtaq, D M Livermore, et al.International Journal of Antimicrobial Agents|May 5, 2001
Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistanceA P Johnson, M Warner, D M LivermorePageof 113